Petra Reinke
Charité
401 Papers
2.5K Citations
Petra Reinke is an academic researcher from Charité. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 64, co-authored 386 publications. Previous affiliations of Petra Reinke include Paracelsus Private Medical University of Salzburg & Center for Cell and Gene Therapy.
Chat about Author
Papers
Patent
Method and kit for testing various selected materials and/or surface structures for culturing cells
Frank Klein,Thomas Weigel,Karl Kratz,Friedrich Jung,Bernhard Hiebl,Andreas Lendlein,Karola Lützow,Andreas Kurtz,Petra Reinke,Andy Römhild +9 more
- 24 Sep 2010
TL;DR: In this paper, a method for testing various selected materials and/or surface structures for culturing cells and microorganisms was proposed, comprising the steps of: i) providing a plurality of various materials and surface structures to be tested in the form of cup-shaped inserts; ii) inserting the cupshaped inserts in recesses of multi-well plates of corresponding sizing such that the exterior side of a cup floor points in the direction of the interior side of the floor of a recess of a multi-Well plate; and iii) culturing of cells in the lumen of the
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.
Benjamin Weist,Patrizia Wehler,Linda El Ahmad,Michael Schmueck-Henneresse,Jason M. Millward,Mikalai Nienen,Avidan U. Neumann,Petra Reinke,Nina Babel,Nina Babel +9 more
TL;DR: This work applied a novel detection strategy for BKV-specific T cells in immunosuppressed kidney transplant patients using these more robust markers, and showed significantly improved sensitivity compared with the conventional IFNγ-based method.
Autoimmunity and transplantation: a meeting at the crossroads in Berlin
TL;DR: The 8th International Conference on New Trends in Immunosuppression and Immunotherapy, 2008, in Berlin discusses new opportunities arising from interactions between basic science and clinical 'translation'.
Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity.
TL;DR: Post‐transplantation diabetes mellitus has been associated with inferior patient and allograft outcomes, but previous studies did not identify differences in infection control and alloreactivity.
Modified ELISPOT technique — Highly significant inverse correlation of post-Tx donor-reactive IFNγ-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients☆
Bele Johanna Näther,Peter Nickel,Gantuja Bold,Franziska Presber,Constanze Schönemann,Johann Pratschke,Hans-Dieter Volk,Petra Reinke +7 more
TL;DR: The results suggest that the modified donor-reactive ELISPOT approach might provide a useful surrogate marker for renal transplant outcome with possible utility especially in T-lymphopenic patients.